/EML

Eastern Company

EML

$24.48USD↓-4.52%-1.16 today

MARKET CAP

147.3M

P/E (TTM)

38.3x

FWD P/E

15.4x

DAY RANGE

$24 – $26

52W RANGE

$18

$30

AI Summary

Stalk

TrimMedium

EML has entered a Stage 3 decline following a decisive support failure below its established trendline and EMAs. The medium-term bias is bearish while the long-term uptrend remains intact above the 200-day SMA. Short-term conditions are oversold and unfavorable for immediate selling; look to initiate short positions on rallies into the broken trendline and 20/50 EMA confluence near 25.50–25.90.

↑FY27 underlying EBITDA guidance $50–54m vs. $48.3m FY26 marks inflection
↑New program pipeline of $109m offers revenue visibility after FY26 decline
↓FY26 underlying revenue fell 6% to $206.8m and EBITDA down 18%

Full analysis →

Buying

3

institutions

Selling

3

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
RT Renaissance Technologies LLC Q2 2026	SELL	131.44 K	3.66 M	+-1.80 K	+35.7%	0.01%
BI Blackrock, Inc. Q2 2026	SELL	40.50 K	1.13 M	+-267.53 K	-81.9%	0.00%
MM Millennium Management LLC Q2 2026	BUYNEW	22.57 K	628.63 K	+22.57 K	+0.0%	0.00%
CA Citadel Advisors LLC Q2 2026	BUYNEW	14.24 K	396.69 K	+14.24 K	+0.0%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUYNEW	12.51 K	348.43 K	+12.51 K	+0.0%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	1.40 K	36.28 K	+-993.00	-24.3%	0.00%